AstraZeneca will host a roundtable at Parliament House in Canberra today. The discussion will focus on a proposal to introduce an Interim Cancer Fund as a bridge for patients to access cancer medicines while they navigate Australia's health technology assessment process.
AstraZeneca roundtable to highlight push for Australian Interim Cancer Fund
March 20, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Can GLP-1s be more transformative than AI - one person believes they already are
July 14, 2026 - - Latest News -
The age-old argument for supermarket pharmacies misses the point, and the risks
July 14, 2026 - - Latest News -
Pharmacy Guild rejects Grattan Institute report, describing community pharmacies as essential health providers
July 13, 2026 - - Latest News -
Immutep cancer candidate shows strong median survival in lung cancer as company consider conflicting trial results
July 13, 2026 - - Australian Biotech -
OncoSil Medical establishes scalable Australian production after successful manufacturing validation
July 13, 2026 - - Australian Biotech -
SCENESSE gains Canadian approval offering long term protection for patients with rare disorder
July 13, 2026 - - Australian Biotech -
Patrys and Yale agree revenue share to advance deoxymab platform
July 13, 2026 - - Australian Biotech

